References
<A NAME="RD30904ST-1">1</A>
Kocienski P.
Barber C.
Pure Appl. Chem.
1990,
62:
1933
<A NAME="RD30904ST-2">2</A>
Kocienski PJ. In
Organic Synthesis via Organometallics
Enders D.
Gais H.-J.
Keim W.
Verlag Vieweg;
Wiesbaden:
1993.
p.203-223
<A NAME="RD30904ST-3">3</A>
Friesen RW.
J. Chem. Soc., Perkin Trans. 1
2001,
1969
<A NAME="RD30904ST-4">4</A>
Kocienski P.
Wadman S.
Cooper K.
J. Am. Chem. Soc.
1989,
111:
2363
<A NAME="RD30904ST-5">5</A>
Milne JE.
Jarowicki K.
Kocienski PJ.
Alonso J.
Chem. Commun.
2002,
426
<A NAME="RD30904ST-6">6</A>
Pommier A.
Stepanenko V.
Jarowicki K.
Kocienski PJ.
J. Org. Chem.
2003,
68:
4008
<A NAME="RD30904ST-7">7</A>
Jarowicki K.
Kocienski PJ.
Qun L.
Org. Synth.
2002,
79:
11
<A NAME="RD30904ST-8">8</A>
We coined the term 1,2-metallate rearrangement to describe a large class of reactions
involving nucleophlic displacement reactions of electrophilic carbenoids (see ref.
1).
<A NAME="RD30904ST-9">9</A>
Sawyer JS.
Kucerovy A.
Macdonald TL.
McGarvey GJ.
J. Am. Chem. Soc.
1988,
110:
842
<A NAME="RD30904ST-10">10</A>
Helmke H.
Hoppe D.
Synlett
1995,
978
<A NAME="RD30904ST-11">11</A> Compounds 14a and 14b were prepared the same way as the corresponding tribenzyl derivatives:
Christopher JA.
Kocienski PJ.
Procter MJ.
Synlett
1998,
425
<A NAME="RD30904ST-12">12</A>
Compounds 17a and 17b were converted into the corresponding methyl ethers 18a and 18b and their structures determined by stereoselective synthesis.
<A NAME="RD30904ST-13">13</A> Although the reaction of organocuprates with alkyl iodides may involve the formation
of radicals, tosylates are considered to react strictly according to an SN2 mechanism: Alkylations of Nonstabilised Carbanions;
Klunder JM.
Posner GH.
Comprehensive Organic Synthesis
Vol. 3:
Trost BM.
Fleming I.
Pergamon Press;
Oxford:
1991.
p.207
<A NAME="RD30904ST-14">14</A> The β-2-deoxyglucosylcopper(I) reagent is configurationally stable at 0 °C but
the α-2-deoxyglucosyl-copper(I) rearranges to the β-anomer at 0 °C:
Hutchinson DK.
Fuchs PL.
J. Am. Chem. Soc.
1987,
109:
4930
<A NAME="RD30904ST-15">15</A>
Periasamy MP.
Walborsky HM.
J. Am. Chem. Soc.
1975,
97:
5930
<A NAME="RD30904ST-16">16</A>
Linderman RJ.
Griedel BD.
J. Org. Chem.
1990,
55:
5428
<A NAME="RD30904ST-17">17</A>
Linderman RJ.
Griedel BD.
J. Org. Chem.
1991,
56:
5491
<A NAME="RD30904ST-18">18</A>
Bergbreiter DE.
Whitesides GM.
J. Am. Chem. Soc.
1974,
96:
4937
<A NAME="RD30904ST-19">19</A>
Whitesides GM.
San Filippo J.
Stredronsky ER.
Casey CP.
J. Am. Chem. Soc.
1969,
91:
6542
<A NAME="RD30904ST-20">20</A>
Yamamoto H.
Kitatani K.
Hiyama T.
Nozaki H.
J. Am. Chem. Soc.
1977,
99:
5816
<A NAME="RD30904ST-21">21</A>
Nakamura E.
Isaka M.
Matsuzawa S.
J. Am. Chem. Soc.
1988,
110:
1297
<A NAME="RD30904ST-22">22</A>
Boudier A.
Hupe E.
Knochel P.
Angew. Chem. Int. Ed.
2000,
39:
2294
<A NAME="RD30904ST-23">23</A>
Hupe E.
Knochel P.
Angew. Chem. Int. Ed.
2001,
40:
3022
<A NAME="RD30904ST-24">24</A>
Rychnovsky SD.
Buckmelter AJ.
Dahanukar VH.
Skalitzky DJ.
J. Org. Chem.
1999,
64:
6849
<A NAME="RD30904ST-25">25</A>
Matteson DS.
Tetrahedron
1998,
54:
10555
<A NAME="RD30904ST-26">26</A>
Hoppe D.
Hense T.
Angew. Chem., Int. Ed. Engl.
1997,
36:
2283
<A NAME="RD30904ST-27">27</A>
Selected Spectroscopic Data for Compounds 7, 11, 13, 18a and 18b:
Compound 7: IR (neat): 3334, 3076, 2956, 2927, 2860, 1639, 1589, 1456 cm-1. 1H NMR (500 MHz, CDCl3): δ = 5.78 (1 H, ddt, J = 16.7, 9.8, 7.3 Hz, H2C=CH), 5.05-4.97 (2 H, m, H
2C=CH), 3.64 (2 H, q, J = 6.4 Hz, CH
2OH), 2.10-2.00 (2 H, m, CH
2CH=CH2), 1.61-1.53 (2 H, m, C2H2), 1.46-1.38 (1 H, m, C4H), 1.35-1.21 (9 H, m, OH, 4 × CH2), 0.90 (3 H, t, J = 6.8 Hz, CH3). 13C NMR (75 MHz, CDCl3): δ = 137.5 (H2C=CH), 115.9 (H2
C=CH), 63.5 (C1H2), 38.2 (CH2CH=CH2), 37.3 (C4H), 33.1 (CH2CH2CH2CH3), 30.1 (C2H2), 29.4 (C3H2), 29.0 (CH2CH2CH3), 23.2 (CH2CH3), 14.3 (CH3). HRMS (ES): m/z calcd for C11H23O [M + H]+: 171.1749. Found: 171.1751.
Compound 11: IR (neat): 3336, 3076, 2927, 2859, 1640, 1458 cm-1. 1H NMR (500 MHz, CDCl3): δ = 5.77 (1 H, ddt, J = 17.1, 10.3, 7.0 Hz, H2C=CH), 5.03-4.96 (2 H, m, H
2C=CH), 3.64 (2 H, t, J = 6.5 Hz, CH
2OH), 2.03 (2 H, t, J = 6.0 Hz, CH
2CH=CH2), 1.55 (2 H, app quintet, J = 6.5 Hz, C2H2), 1.46-1.20 (12 H, m, OH, C5H, 5 × CH2), 0.89 (3 H, t, J = 6.5 Hz, CH3). 13C NMR (75 MHz, CDCl3): δ = 137.7 (H2C=CH), 115.8 (H2
C=CH), 63.2 (C1H2), 38.2 (CH2CH=CH2), 37.5 (C5H), 33.3 (CH2), 33.3 (CH2), 33.2 (CH2), 29.1 (CH2CH2CH3), 23.2 (CH2), 23.0 (CH2), 14.3 (CH3). HRMS (ES): m/z calcd for C12H24ONa [M + Na]+: 207.1725. Found: 207.1719.
Compound 13: IR (neat): 3075, 2928, 2858, 1639, 1589, 1508 cm-1. 1H NMR (500 MHz, CDCl3): δ = 6.40 (2 H, s, 2 ArH), 5.80 (1 H, ddt, J = 17.1, 10.3, 6.8 Hz, H2C=CH), 4.92-4.83 (2 H, m, H
2C=CH), 3.86 (6 H, s, 2 m-CH3O), 3.83 (3 H, s, p-CH3O), 2.56 (2 H, dd, J = 9.4, 6.4 Hz, CH
2Ar), 2.11 (2 H, t, J = 6.4 Hz, CH
2CH=CH2), 1.48-1.37 (2 H, m, CH
2CH2Ar), 1.35-1.26 (1 H, m, CH), 1.22-1.08 (6 H, m, 3 × CH2), 0.91 (3 H, t, J = 6.8 Hz, CH3). 13C NMR (75 MHz, CDCl3): δ = 153.1 (2 COCH3, Ar ring), 139.0 (C, Ar ring), 137.4 (H2C=CH), 136.0 (COCH3, Ar ring), 116.0 (H2
C=CH), 105.2 (2 CH, Ar ring), 61.0 (CH3O), 56.1 (2 CH3O), 38.1 (CH2CH=CH2), 37.2 (CHCH2CH=CH2), 35.4 (CH2CH2Ar), 33.7 (CH2Ar), 33.1 (CH2CH2CH2CH3), 29.0 (CH2CH2CH3), 23.2 (CH2CH3), 14.3 (CH3). HRMS (ES): m/z calcd for C19H31O3 [M + H]+: 307.2273. Found: 307.2281.
Compound 18a: [α]D +12.3 (c 0.70, CHCl3). IR (neat): 2955, 2927, 2826, 1459, 1378, 1186, 1103 cm-1. 1H NMR (500 MHz, CDCl3): δ = 3.69 (1 H, dd, J = 10.7, 2.6 Hz, C1H
AHB), 3.50 (1 H, dd, J = 10.9, 3.6 Hz, C1HA
H
B), 3.50-3.36 (2 H, m, C2H and C4H), 3.46 (3 H, s, CH3O), 3.42 (3 H, s, CH3O), 3.40 (3 H, s, CH3O), 3.39 (3 H, s, CH3O), 3.24 (1 H, dd, J = 7.7, 3.0 Hz, C3H), 1.65 (1 H, ddd, J = 13.3, 7.7, 6.0 Hz, C5H
AHB), 1.62-1.53 (1 H, m, C6H), 1.37-1.10 (7 H, m, C5HA
H
B and 3 × CH2), 0.92 (3 H, d, J = 6.4 Hz, CH
3C6H), 0.89 (3 H, t, J = 6.4 Hz, C10H3). 13C NMR (75 MHz, CDCl3): δ = 81.7 (C3H), 79.8 (C2H), 78.4 (C4H), 70.3 (C1H2), 61.0 (CH3O), 59.2 (CH3O), 58.8 (CH3O), 57.5 (CH3O), 38.5 (C5H2), 37.3 (C7H2), 29.5 (C6H), 29.3 (C8H2), 23.2 (C9H2), 20.1 (CH3C6H), 14.3 (C10H3). HRMS (ES): m/z calcd for C15H32O4Na [M + Na]+: 299.2198. Found: 299.2190.
Compound 18b: IR (neat): 2955, 2927, 2826, 1462, 1377, 1186, 1103 cm-1. 1H NMR (500 MHz, CDCl3): δ = 3.72 (1 H, dd, J = 10.3, 2.1 Hz, C1H
AHB), 3.51 (1 H, dd, J = 10.7, 3.4 Hz, C1HA
H
B), 3.49-3.36 (2 H, m, C2H and C4H), 3.46 (3 H, s, CH3O), 3.42 (3 H, s, CH3O), 3.40 (3 H, s, CH3O), 3.37 (3 H, s, CH3O), 3.26 (1 H, dd, J = 7.7, 2.1 Hz, C3H), 1.59 (1 H, ddd, J = 13.3, 8.1, 4.7 Hz, C5H
AHB), 1.57-1.46 (1 H, m, C6H), 1.42 (1 H, ddd, J = 13.7, 8.5, 6.0 Hz, C5HA
H
B), 1.39-1.13 (6 H, m, 3 × CH2), 0.91 (3 H, d, J = 6.4 Hz, CH
3C6H), 0.89 (3 H, t, J = 6.8 Hz, C10H3). 13C NMR (75 MHz, CDCl3): δ = 80.3 (C3H), 79.6 (C2H), 78.4 (C4H), 70.2 (C1H2), 61.0 (CH3O), 59.2 (CH3O), 58.0 (CH3O), 57.6 (CH3O), 37.5 (C7H2), 37.1 (C5H2), 29.5 (C6H), 29.3 (C8H2), 23.1 (C9H2), 20.2 (CH3C6H), 14.3 (C10H3). HRMS (ES): m/z calcd for C15H32O4Na [M + Na]+: 299.2198. Found: 299.2197.